Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs
NCT04499001 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2020-08-05
Summary
There is a lack of knowledge among patients concerning their treatment with bDMARDs. To increase knowledge and safety skills, patient education is essential.
The aim of this study is to assess the impact of a pharmacist's educational interview on on knowledge and safety skills to bDMARDs in patients with inflammatory arthritis.
Conditions
- Arthritis, Rheumatoid
- Spondyloarthritis
- Biological Therapy
Interventions
- OTHER
-
Pharmacist's consultation
Information about bDMARDs management.
Sponsors & Collaborators
-
Hôpital Cochin
lead OTHER
Principal Investigators
-
Cécile Bottois, Dr · Hôpital Cochin
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2020-07-31
- Completion
- 2020-07-31
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Condition of Rheumatoid Arthritis After Treatment
NCT02157012 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
NCT05428488 ·Status: RECRUITING ·Phase: PHASE3
-
Therapeutic Strategy Associated With bDMARDs or tsDMARDs in Rheumatoid Arthritis and Psoriatic Arthritis
NCT05082805 ·Status: UNKNOWN
-
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
NCT01559103 ·Status: TERMINATED ·Phase: PHASE1
-
A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis
NCT00236028 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Rheumatoid Arthritis
NCT01253265 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients
NCT02089087 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment
NCT05516979 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults
NCT07235163 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis
NCT00779220 ·Status: TERMINATED ·Phase: PHASE2
-
Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)
NCT01308255 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01519791 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis
NCT00838565 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
NCT02309359 ·Status: COMPLETED ·Phase: PHASE2
-
Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients
NCT00669942 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01521923 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis
NCT01050998 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate
NCT06724952 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis
NCT03110094 ·Status: COMPLETED ·Phase: NA
-
A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)
NCT06213259 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
NCT05049798 ·Status: ACTIVE_NOT_RECRUITING
-
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
NCT00116714 ·Status: COMPLETED
-
Italian Registry of Arthritis on Biologic Therapy
NCT01543594 ·Status: RECRUITING
-
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
NCT00760669 ·Status: COMPLETED
-
A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
NCT00550043 ·Status: COMPLETED ·Phase: PHASE2